Trust Investment Advisors Buys Shares of 3,433 CME Group Inc. $CME

Trust Investment Advisors purchased a new position in CME Group Inc. (NASDAQ:CME) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 3,433 shares of the financial services provider’s stock, valued at approximately $1,014,000.

Other large investors have also made changes to their positions in the company. Asset Dedication LLC grew its stake in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC boosted its holdings in CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after acquiring an additional 37 shares in the last quarter. Rehmann Capital Advisory Group boosted its holdings in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares in the last quarter. 1248 Management LLC grew its stake in shares of CME Group by 26.8% during the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after acquiring an additional 38 shares during the last quarter. Finally, Sovran Advisors LLC increased its holdings in shares of CME Group by 3.5% during the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock valued at $305,000 after acquiring an additional 38 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Keefe, Bruyette & Woods upgraded CME Group (CME) to Outperform from Market Perform and kept a $305 price target, citing an attractive risk/reward setup after recent stock weakness. Article Title
• Positive Sentiment: Insider buying may also support sentiment: Director William Shepard bought 325 shares at about $230.57 per share, signaling confidence from management. Article Title
• Positive Sentiment: Analysts still expect modest earnings growth ahead of CME’s next report, and one note lifted FY2027 EPS estimates slightly, reinforcing the view that fundamentals remain solid. Article Title
• Neutral Sentiment: CME is expected to report second-quarter results soon, with Wall Street looking for low-single-digit profit growth; investors may be waiting for the print before making bigger moves. Article Title
• Negative Sentiment: Goldman Sachs cut its price target on CME Group (CME) to $245 from $267 and maintained a Sell rating, which likely weighed on the stock. Article Title
• Negative Sentiment: DraftKings’ move to bring its prediction-markets infrastructure in-house may reduce reliance on third-party platforms such as CME over time, creating a potential competitive headwind. Article Title

Analysts Set New Price Targets

A number of research firms recently commented on CME. Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Argus restated a “hold” rating on shares of CME Group in a research note on Wednesday, March 4th. The Goldman Sachs Group decreased their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday. Morgan Stanley dropped their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Finally, UBS Group reissued an “overweight” rating on shares of CME Group in a research report on Monday, June 15th. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $300.94.

Insider Buying and Selling at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is currently owned by corporate insiders.

CME Group Trading Up 4.6%

NASDAQ CME opened at $231.00 on Thursday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $83.70 billion, a PE ratio of 19.71, a P/E/G ratio of 2.47 and a beta of 0.21. The company has a fifty day moving average of $269.11 and a 200 day moving average of $284.88.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period last year, the firm earned $2.80 EPS. Research analysts forecast that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were issued a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.3%. CME Group’s payout ratio is presently 44.37%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.